Correlation Between Adamis Pharma and Dynavax Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adamis Pharma and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adamis Pharma and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adamis Pharma and Dynavax Technologies, you can compare the effects of market volatilities on Adamis Pharma and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adamis Pharma with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adamis Pharma and Dynavax Technologies.

Diversification Opportunities for Adamis Pharma and Dynavax Technologies

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Adamis and Dynavax is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Adamis Pharma and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Adamis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adamis Pharma are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Adamis Pharma i.e., Adamis Pharma and Dynavax Technologies go up and down completely randomly.

Pair Corralation between Adamis Pharma and Dynavax Technologies

If you would invest  1,290  in Dynavax Technologies on November 2, 2024 and sell it today you would earn a total of  11.00  from holding Dynavax Technologies or generate 0.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy5.26%
ValuesDaily Returns

Adamis Pharma  vs.  Dynavax Technologies

 Performance 
       Timeline  
Adamis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adamis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Adamis Pharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Dynavax Technologies 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Adamis Pharma and Dynavax Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adamis Pharma and Dynavax Technologies

The main advantage of trading using opposite Adamis Pharma and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adamis Pharma position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.
The idea behind Adamis Pharma and Dynavax Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.